IPRIPR2022-01225Final Written Decision
Mylan Pharmaceuticals Inc. et al.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 10130681.
Type
IPR
Filed
Jul 1, 2022
Instituted
Jan 11, 2023
Decided
Aug 23, 2024
Patent
Application
15471506
Inventor
George D. YANCOPOULOS
Granted
Nov 20, 2018
01
Timeline
3 milestones
2022-07-01Petition filed
2023-01-11Institution
2024-01-09Terminated
02
Parties & counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Counsel
Molino, Paulet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Fishman, Deborahet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →